Does vitamin D protect against respiratory viral infections?

Epidemiology and Infection

Volumn 142, Issue 9, 2014, Pages 1789-1801

  Bryson, K J ^a   Nash, A A ^a   Norval, M ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Influenza (seasonal); respiratory syncytial virus; respiratory viral infections; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA INTERFERON; BETA INTERFERON; CALCITRIOL; COLECALCIFEROL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; RANTES; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR; ANTIBIOTIC AGENT; CALCIFEDIOL; INFLUENZA VACCINE; PARICALCITOL; TRIPLE VACCINE;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; INCIDENCE; INFECTION RISK; INNATE IMMUNITY; MACROPHAGE; PROTEIN FUNCTION; REVIEW; ULTRAVIOLET B RADIATION; VACCINATION; VIRAL CLEARANCE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; CLINICAL STUDY; DRUG EFFICACY; FLU LIKE SYNDROME; IMMUNOMODULATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA B; INFLUENZA VACCINATION; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; PNEUMONIA; UPPER RESPIRATORY TRACT INFECTION; VIRUS NEUTRALIZATION;

HUMANS; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES; VITAMIN D;

EID: 84904600783     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814000193     Document Type: Review

References (70)

1. Reed G, et al. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. Journal of Infectious Diseases 1997; 175: 807-813.
2. Nair H, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375: 1545-1555.
3. Nair H, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011; 378: 1917-1930.
4. Juzeniene A, et al. The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D. International Journal of Infectious Diseases 2010; 14: e1099-1105.
5. Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatric Respiratory Reviews 2003; 4: 105-111.
6. Hope-Simpson RE. The role of season in the epidemiology of influenza. Journal of Hygiene 1981; 86: 35-47.
7. Hayes DP. Influenza pandemics, solar activity cycles, and vitamin D. Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children. Medical Hypotheses 2010; 74: 831-834.
8. Holick MF. Vitamin D: a d-lightful solution for health. Journal of Investigative Medicine 2011; 59: 872-880.
9. Kazantzidis A, et al. Calculations of the human vitamin D exposure from UV spectral measurements at three European stations. Photochemical and Photobiological Sciences 2009; 8: 45-51.
10. Diffey BL. Modelling vitamin D status due to oral intake and sun exposure in an adult British population. British Journal of Nutrition 2013; 110: 569-577.
11. Kasahara AK, Singh RJ, Noymer A. Vitamin D (25OHD) Serum Seasonality in the United States. PLoS One 2013; 8: e65785.
12. Fraser WD, Milan AM. Vitamin D assays: past and present debates, difficulties, and developments. Calcified Tissue International 2013; 92: 118-127.
13. Cranney A, et al. Effectiveness and safety of vitamin D in relation to bone health. Evidence Report/Technology Assessment (Full Report) 2007; 158: 1-235.
14. Ross AC, et al. (eds). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011.
15. Heaney RP. Assessing vitamin D status. Current Opinion in Clinical Nutrition & Metabolic Care 2011; 14: 440-444.
16. Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Immune responses to influenza virus infection. Virus Research 2011; 162: 19-30.
17. Nakano M, et al. Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells. Clinical and Experimental Immunology 2012; 170: 94-100.
18. Milde P, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. Journal of Investigative Dermatology 1991; 97: 230-239.
19. Kresfelder TL, et al. Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children. Journal of Medical Virology 2011; 83: 1834-1840.
20. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. Journal of Clinical Virology 2011; 50: 194-200.
21. Barlow PG, et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 2011; 6: e25333.
22. Cannell JJ, et al. Epidemic influenza and vitamin D. Epidemiology and Infection 2006; 134: 1129-1140.
23. Tumpey TM, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. Journal of Virology 2005; 79: 14933-14944.
24. Khare D, et al. Calcitriol [1,25[OH]2D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. European Journal of Nutrition 2013; 52: 1405-1415.
25. Zhou Z, et al. Autophagy is involved in influenza A virus replication. Autophagy 2009; 5: 321-328.
26. Khoo AL, et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clinical and Experimental Immunology 2011; 164: 72-79.
27. Enioutina EY, Bareyan D, Daynes RA. TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 2008; 26: 601-613.
28. Hansdottir S, et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. Journal of Immunology 2010; 184: 965-974.
29. de Jong MD, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Medicine 2006; 12: 1203-1207.
30. + T cells. Journal of Immunology 2002; 168: 1181-1189.
31. Froicu M, et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Molecular Endocrinology 2003; 17: 2386-2392.
32. Bruce D, et al. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. International Immunology 2011; 23: 519-528.
33. Kang SW, et al. 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. Journal of Immunology 2012; 188: 5276-5282.
34. Urry Z, et al. The role of 1alpha,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. European Journal of Immunology 2012; 42: 2697-2708.
35. Gorman S, Judge MA, Hart PH. Topical 1,25- dihydroxyvitamin D3 subverts the priming ability of draining lymph node dendritic cells. Immunology 2010; 131: 415-425.
36. Antunes I, Kassiotis G. Suppression of innate immune pathology by regulatory T cells during influenza A virus infection of immunodeficient mice. Journal of Virology 2010; 84: 12564-12575.
37. Najada AS, Habashneh MS, Khader M. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases. Journal of Tropical Pediatrics 2004; 50: 364-368.
38. Wayse V, et al. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. European Journal of Clinical Nutrition 2004; 58: 563-567.
39. Roth DE, et al. Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. European Journal of Clinical Nutrition 2009; 63: 297-299.
40. Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 2009; 169: 384-390.
41. Roth DE, et al. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatrica 2010; 99: 389-393.
42. Sabetta JR, et al. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010; 5: e11088.
43. Jartti T, et al. Low serum 25-hydroxyvitamin D levels are associated with increased risk of viral coinfections in wheezing children. Journal of Allergy and Clinical Immunology 2010; 126: 1074-1076.
44. Asamura T, et al. Low serum 1,25-dihydroxyvitamin D level and risk of respiratory infections in institutionalized older people. Gerontology 2010. 56: 542-543.
45. Berry DJ, et al. Vitamin D status has a linear association with seasonal infections and lung function in British adults. British Journal of Nutrition 2011; 106: 1433-1440.
46. Porojnicu AC, et al. Vitamin D status in healthy Romanian caregivers and risk of respiratory infections. Public Health Nutrition 2012; 15: 2157-2162.
47. Hirani V. Associations between vitamin D and selfreported respiratory disease in older people from a nationally representative population survey. Journal of the American Geriatric Society 2013; 61: 969-973.
48. Karatekin G, et al. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. European Journal of Clinical Nutrition 2009; 63: 473-477.
49. Camargo CA, et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 2011; 127: e180-187.
50. Belderbos ME, et al. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 2011; 127: e1513-1520.
51. Morales E, et al. Maternal vitamin D status in pregnancy and risk of lower respiratory tract infections, wheezing, and asthma in offspring. Epidemiology 2012; 23: 64-71.
52. Li-Ng M, et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiology and Infection 2009; 137: 1396-1404.
53. Laaksi I, et al. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. Journal of Infectious Diseases 2010; 202: 809-814.
54. Urashima M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. American Journal of Clinical Nutrition 2010; 91: 1255-1260.
55. Manaseki-Holland S, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Tropical Medicine and International Health 2010; 15: 1148-1155.
56. Murdoch DR, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. Journal of the American Medical Association 2012; 308: 1333-1339.
57. Manaseki-Holland S, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 2012; 379: 1419-1427.
58. Camargo CA, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012; 130: e561-567.
59. Bjorkhem-Bergman L, et al. Serum levels of 25- hydroxyvitamin D and the CYP3A biomarker 4betahydroxycholesterol in a high-dose vitamin D supplementation study. Drug Metabolism and Disposition 2013; 41: 704-708.
60. de Gruijl FR, Pavel S. The effects of a mid-winter 8-week course of sub-sunburn sunbed exposures on tanning, vitamin D status and colds. Photochemical and Photobiological Sciences 2012; 11: 1848-1854.
61. Daynes RA., et al. Steroids as regulators of the mammalian immune response. Journal of Investigative Dermatology 1995; 105(1 Suppl): 14S-19S.
62. Kriesel JD, Spruance J. Calcitriol (1,25-dihydroxyvitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 1999; 17: 1883-1888.
63. Moe SM, et al. A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol. American Journal of Kidney Diseases 2001; 38: 792-802.
64. Chadha MK, et al. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 2011; 71: 368-372.
65. Cooper C, Thorne A. Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults. HIV Clinical Trials 2011; 12: 275-276.
66. Momplaisir F, et al. Vitamin D levels, natural H1N1 infection and response to H1N1 vaccine among HIVinfected individuals. Journal of AIDS and Clinical Research 2012; 3: 152-159.
67. Principi N, et al. Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children. Human Vaccines and Immunotherapeutics 2013; 9: 969-974.
68. Hollis BW, Wagner CL. The role of parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. Journal of Clinical Endocrinology & Metabolism 2013; 98: 4619-4628.
69. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nature Reviews Immunology 2011; 11: 584-596.
70. Milliken SV, et al. Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function. Journal of Allergy and Clinical Immunology 2012; 129: 1554-1561.